Imperva (NASDAQ: IMPV) is one of 183 public companies in the “IT Services & Consulting” industry, but how does it weigh in compared to its rivals? We will compare Imperva to related businesses based on the strength of its valuation, institutional ownership, profitability, analyst recommendations, earnings, risk and dividends.

Profitability

This table compares Imperva and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva 3.04% -8.52% -4.99%
Imperva Competitors -20.53% -255.25% -4.33%

Analyst Ratings

This is a summary of recent ratings for Imperva and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 2 6 8 0 2.38
Imperva Competitors 744 4653 7408 167 2.54

Imperva presently has a consensus price target of $51.33, indicating a potential upside of 25.82%. As a group, “IT Services & Consulting” companies have a potential downside of 5.60%. Given Imperva’s higher possible upside, analysts clearly believe Imperva is more favorable than its rivals.

Institutional and Insider Ownership

97.0% of Imperva shares are held by institutional investors. Comparatively, 63.0% of shares of all “IT Services & Consulting” companies are held by institutional investors. 1.9% of Imperva shares are held by insiders. Comparatively, 16.5% of shares of all “IT Services & Consulting” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Imperva has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Imperva’s rivals have a beta of 1.12, indicating that their average share price is 12% more volatile than the S&P 500.

Earnings & Valuation

This table compares Imperva and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Imperva $264.45 million -$70.27 million 151.12
Imperva Competitors $2.79 billion $290.02 million 325.23

Imperva’s rivals have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Imperva rivals beat Imperva on 7 of the 12 factors compared.

About Imperva

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive News & Stock Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related stocks with our FREE daily email newsletter.